Tuis2359 • HKG
add
WuXi AppTec Ord Shs H
Vorige sluiting
$97,40
Dagwisseling
$97,40 - $99,15
Jaarwisseling
$44,30 - $124,70
Markkapitalisasie
293,08 mjd HKD
Gemiddelde volume
5,96 m
P/V-verhouding
17,59
Dividend-opbrengs
1,46%
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 12,04 mjd | 15,14% |
Bedryfskoste | 1,38 mjd | — |
Netto inkomste | 3,51 mjd | — |
Netto winsgrens | 29,18 | — |
Wins per aandeel | 1,24 | 61,04% |
EBITDA | 5,21 mjd | — |
Effektiewe belastingkoers | 30,19% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 33,74 mjd | 140,13% |
Totale bates | 94,61 mjd | 27,44% |
Totale aanspreeklikheid | 23,13 mjd | 24,01% |
Totale ekwiteit | 71,47 mjd | — |
Uitstaande aandele | 2,87 mjd | — |
Prys om te bespreek | 3,93 | — |
Opbrengs op bates | 12,87% | — |
Opbrengs op kapitaal | 15,11% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 3,51 mjd | — |
Kontant van bedrywe | 3,98 mjd | — |
Kontant van beleggings | -1,40 mjd | — |
Kontant van finansiering | 5,35 mjd | — |
Netto kontantverandering | 7,92 mjd | — |
Beskikbare kontantvloei | -1,63 mjd | — |
Meer oor
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. Wikipedia
Gestig
01 Des. 2000
Webwerf
Werknemers
37 832
